Peter D. Kwong mainly investigates Antibody, Virology, Epitope, Neutralization and Protein structure. Peter D. Kwong has included themes like Molecular biology, Glycoprotein, Antigen and Immune system in his Antibody study. His Virology research is multidisciplinary, incorporating elements of AIDS Vaccines, Immunization and Immunology.
His Epitope research includes elements of Viral envelope, Motavizumab and Glycan. His studies deal with areas such as Glycosylation and Primary and secondary antibodies as well as Neutralization. His study in Protein structure is interdisciplinary in nature, drawing from both Biophysics, Gp41 and Binding site.
Peter D. Kwong mainly focuses on Virology, Antibody, Epitope, Neutralization and Glycoprotein. His Virology research focuses on subjects like Monoclonal antibody, which are linked to In vitro. The Antibody study combines topics in areas such as Protein structure, Binding site, Antigen and Glycan.
His Epitope study incorporates themes from Molecular biology and Peptide sequence. His Neutralization research integrates issues from Viral envelope, Mutation, Somatic hypermutation, Potency and Immunization. His Glycoprotein study combines topics in areas such as Biophysics, Envelope and Cell biology.
His primary areas of study are Antibody, Virology, Neutralization, Virus and Epitope. Peter D. Kwong has researched Antibody in several fields, including In vitro, Antigen and Glycan. His research integrates issues of Immunization and Monoclonal antibody in his study of Virology.
The various areas that Peter D. Kwong examines in his Neutralization study include Mutation, Mutant, Computational biology and Avidity. As a member of one scientific family, he mostly works in the field of Virus, focusing on Adjuvant and, on occasion, Immune system. Peter D. Kwong interconnects Neutralizing antibody and Fusion protein in the investigation of issues within Epitope.
Peter D. Kwong focuses on Antibody, Virology, Severe acute respiratory syndrome coronavirus 2, Epitope and Monoclonal antibody. In the subject of general Antibody, his work in Immunization is often linked to Antibody Classes, thereby combining diverse domains of study. His work on Neutralization and Titer as part of general Virology study is frequently linked to Coronavirus, therefore connecting diverse disciplines of science.
His Neutralization study integrates concerns from other disciplines, such as Mutation, Viral evolution and IC50. His research on Epitope frequently connects to adjacent areas such as Neutralizing antibody. His work deals with themes such as Endosome, Globular protein and Binding domain, which intersect with Neutralizing antibody.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
Peter D. Kwong;Richard Wyatt;James Robinson;Raymond W. Sweet.
Antibody neutralization and escape by HIV-1
Xiping Wei;Julie M. Decker;Shuyi Wang;Huxiong Hui.
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu;Zhi Yong Yang;Yuxing Li;Carl Magnus Hogerkorp.
The antigenic structure of the HIV gp120 envelope glycoprotein
Richard Wyatt;Peter D. Kwong;Elizabeth Desjardins;Raymond W. Sweet.
Structural basis of cell-cell adhesion by cadherins.
Lawrence Shapiro;Allison M. Fannon;Peter D. Kwong;Andrew Thompson.
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
Pengfei Wang;Manoj S. Nair;Lihong Liu;Sho Iketani;Sho Iketani.
Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.
Tongqing Zhou;Ivelin Georgiev;Xueling Wu;Zhi Yong Yang.
A Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding
Carlo D. Rizzuto;Richard Wyatt;Richard Wyatt;Nivia Hernández-Ramos;Nivia Hernández-Ramos;Ying Sun;Ying Sun.
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
Peter D. Kwong;Peter D. Kwong;Michael L. Doyle;Michael L. Doyle;David J. Casper;Claudia Cicala.
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.
Lihong Liu;Pengfei Wang;Manoj S. Nair;Jian Yu.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: